BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7694002)

  • 1. An interferon resistant variant of the hairy-cell leukemic cell line, Eskol: biochemical and immunological characterization.
    Ozes ON; Klein SB; Reiter Z; Taylor MW
    Leuk Res; 1993 Nov; 17(11):983-90. PubMed ID: 7694002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine and natural killing regulation of growth of a hairy cell leukemia-like cell line: the role of interferon-alpha and interleukin-2.
    Reiter Z; Ozes ON; Blatt LM; Taylor MW
    J Immunother (1991); 1992 Jan; 11(1):40-9. PubMed ID: 1734947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
    Reiter Z; Taylor MW
    Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alpha-interferon and lymphokine-activated killer cells in hairy cell leukemia.
    Griffiths SD; Cawley JC
    Leukemia; 1988 Jun; 2(6):377-81. PubMed ID: 3374170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of a new cell line (ESKOL) resembling hairy-cell leukemia: a model for oncogene regulation and late B-cell differentiation.
    Harvey W; Srour EF; Turner R; Carey R; Maze R; Starrett B; Kanagala R; Pereira D; Merchant P; Taylor M
    Leuk Res; 1991; 15(8):733-44. PubMed ID: 1895754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of the expression of major histocompatibility antigens on splenic hairy cells--differential effect upon in vitro treatment with alpha-2b-interferon, gamma-interferon, and interleukin-2.
    Gressler VH; Weinkauff RE; Franklin WA; Golomb HM
    Blood; 1988 Sep; 72(3):1048-53. PubMed ID: 3137982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hairy cell leukemia cells are relatively NK-insensitive targets.
    Starling GC; Nimmo JC; Hart DN
    Pathology; 1988 Oct; 20(4):361-5. PubMed ID: 2977221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-alpha 2b and vesnarinone influence levels of tumor necrosis factor-alpha, apoptosis, or interleukin 6 in ESKOL, a hairy cell leukemic cell line. A potential cytokine and oncogene relationship regulating apoptosis is suggested.
    Khalaf W; Maina C; Byers J; Harvey W
    Leuk Res; 2002 Feb; 26(2):169-77. PubMed ID: 11755467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B-cell growth factor-induced and alpha-interferon-inhibited proliferation of hairy cells coincides with modulation of cell surface antigens.
    Gamliel H; Brownstein BH; Gurfel D; Wu SH; Rosner MC; Golomb HM
    Cancer Res; 1990 Jul; 50(13):4111-20. PubMed ID: 2354460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of interferon-Con1 with natural recombinant interferons-alpha: antiviral, antiproliferative, and natural killer-inducing activities.
    Ozes ON; Reiter Z; Klein S; Blatt LM; Taylor MW
    J Interferon Res; 1992 Feb; 12(1):55-9. PubMed ID: 1573283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effects of phorbol ester and interferon-alpha: target cell class I HLA antigen expression and resistance to natural killer and lymphokine-activated killer cell-mediated cytolysis.
    Migita K; Eguchi K; Akiguchi I; Ida H; Kawakami A; Ueki Y; Kurata A; Fukuda T; Nagataki S
    Cell Immunol; 1991 May; 134(2):325-35. PubMed ID: 2021973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigen expression and malignant mesothelioma.
    Christmas TI; Manning LS; Davis MR; Robinson BW; Garlepp MJ
    Am J Respir Cell Mol Biol; 1991 Sep; 5(3):213-20. PubMed ID: 1910807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine-induced enhancement of the susceptibility of hairy cell leukaemia lymphocytes to natural killer cell lysis.
    Cordingley FT; Hoffbrand AV; Brenner MK
    Br J Haematol; 1988 Sep; 70(1):37-41. PubMed ID: 3140887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine loop of tumor necrosis factor induced by interferon-alpha in tumor cells from hairy cell leukemia.
    Romquin N; Billard C
    Leukemia; 1995 Jan; 9(1):87-94. PubMed ID: 7845033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-alpha-2b downregulation of oncogenes H-ras, c-raf-2, c-kit, c-myc, c-myb and c-fos in ESKOL, a hairy cell leukemic line, results in temporal perturbation of signal transduction cascade.
    Harvey WH; Harb OS; Kosak ST; Sheaffer JC; Lowe LR; Heerema NA
    Leuk Res; 1994 Aug; 18(8):577-85. PubMed ID: 7520517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of CD38 gene expression in leukemic B cells by interferon types I and II.
    Bauvois B; Durant L; Laboureau J; Barthélémy E; Rouillard D; Boulla G; Deterre P
    J Interferon Cytokine Res; 1999 Sep; 19(9):1059-66. PubMed ID: 10505750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Mechanism of action of interferon-alpha 2 in hairy cells and lymphoblastoid cell lines: the significance of type I interferon receptors and RNA synthesis].
    Schwabe M; Wagner L; Prischl F; Pinter G; Schwarzmeier JD
    Onkologie; 1988 Aug; 11(4):155-8. PubMed ID: 2972979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.